Genetic differences may affect vitamin E – cancer relationship
The effects of vitamin E status on the risk of prostate cancer may be modulated by genetic differences in enzymes that control oxidative stress, according to new research.
Archives for August 2, 2011
€6m EU project tackles herbal supplement issues
‘European Union project number 245199’ may provide some of the answers to the complex problem of regulating botanicals across the bloc with about 100 scientists, regulators and stakeholders working on the four-year, €6m project.
Herbalife to expand manufacturing footprint
Direct selling supplements giant Herbalife aims to expand its manufacturing footprint dramatically over the next two-to-four years as it steps up plans to make more of its products in-house.
Rooster comb extract close to novel food approval
An application to allow an extract from the combs of cockerels to be used in dairy products is nearing the end as it is said to pose no significant safety concerns.
CAM industry tension rises as UK advertising watchdog claims clampdown continues
The UK complementary and alternative medicines (CAM) sector that includes purveyors of botanical extracts has come away from a meeting with UK Advertising Standards Authority (ASA) officers with heightened concerns about the watchdog’s methods.
NDI guidance public comments: Don't revise it, ditch it
The FDA should calculate how much complying with its guidance on new dietary ingredients (NDIs) will cost before forcing the supplements industry to embark on a “giant paperwork exercise” that will not make consumers any safer, according to the first...
Lonza L-Carnitine is not from animal sources
Yesterday’s article Carnitine transporter may adapt to lower levels in vegetarians: Study incorrectly stated that Lonza’s L-Carnitine ingredient Carnipure is derived from animal sources. In fact, it is vegetarian.
EFSA health claim opinion
Kraft on positive glycaemic health claim opinion: “We are only halfway through the process”
Kraft Foods Europe is “delighted” to have become only the second company to win an article 13.5 health claim but is focusing now on how the opinion will be viewed by the European Commission and member states.